122. Superficial siderosis Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 3 / Drugs : 3 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0
Drugs and their primary sponsors and trial info
Balance
University College, London
2020 - NCT04200664 United Kingdom;
DNA bio-banking
University College, London
2020 - NCT04200664 United Kingdom;
Deferiprone
Department of Neurology, Tokyo Medical and Dental University
2024 - JPRN-UMIN000021218 Japan;
Sanjo Nobuo
2019 - JPRN-jRCTs031180438 Japan;
IP6
Superficial Siderosis Research Alliance Inc.
2021 - NCT04890808 -
Inosine
Superficial Siderosis Research Alliance Inc.
2021 - NCT04890808 -
University College, London
2020 - NCT04200664 United Kingdom;
DNA bio-banking
University College, London
2020 - NCT04200664 United Kingdom;
Deferiprone
Department of Neurology, Tokyo Medical and Dental University
2024 - JPRN-UMIN000021218 Japan;
Sanjo Nobuo
2019 - JPRN-jRCTs031180438 Japan;
IP6
Superficial Siderosis Research Alliance Inc.
2021 - NCT04890808 -
Inosine
Superficial Siderosis Research Alliance Inc.
2021 - NCT04890808 -